Monsanto Is A Sell On Earnings - Cramer's Lightning Round (7/20/16)

|
Includes: CSAL, DLR, MON, SGYP, TEVA
by: SA Editor Mohit Manghnani

Summary

Synergy Pharmaceuticals is in a tough situation.

Communications Sales & Leasing has a good yield.

Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Wednesday, July 20.

Bullish Call

Communications Sales & Leasing (NASDAQ:CSAL): It's a good stock with a great yield. Cramer likes Digital Realty (NYSE:DLR) too.

Bearish Calls

Synergy Pharmaceuticals (NASDAQ:SGYP): "I am frustrated with the situation. I do believe that the Allergan money from Teva (NASDAQ:TEVA) is going to come in within the next couple of weeks. Remember, they thought it would come in by July and July is almost over."

Monsanto (NYSE:MON): The stock is up on a takeover basis but cannot be recommended on earnings basis.

:::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::

Jim Cramer's Action Alerts PLUS: Check out Cramer's multi-million dollar charitable trust portfolio and uncover the stocks he thinks could be HUGE winners. Start your FREE 14-day trial now!

Get Cramer's Picks by email - it's free and takes only a few seconds to sign up.